Sign inJoin waitlistJoin the waitlist

AK

Anita Kumar

Associate Attending Physician · New York Presbyterian Hospital

Credentials: · · · · ·

History

Memorial Sloan Kettering Cancer Center
2020–Present

Memorial Sloan Kettering Cancer Center
2011–2013
Internal Medicine
Brigham and Women's Hospital
2008–2011
Feinberg School of Medicine
2004–2008

Research

CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer
Nature Medicine · 2021 · 433 citations
PET-adapted sequential salvage therapy with brentuximab vedotin followed by augmented ifosamide, carboplatin, and etoposide for patients with relapsed and refractory Hodgkin's…
The Lancet Oncology · 2015 · 221 citations
Follicular lymphoma in the modern era: survival, treatment outcomes, and identification of high-risk subgroups
Blood Cancer Journal · 2020 · 181 citations

AZ
Andrew Zelenetz
56 papers
AM
Alison Moskowitz
46 papers
AN
Ariela Noy
46 papers
PH
Paul Hamlin
46 papers
Matthew Matasar
41 papers
SH
Steven Horwitz
39 papers
Lia Palomba
36 papers
AD
Ahmet Dogan
32 papers
GS
Gilles Salles
31 papers
AY
Anas Younes
28 papers
DS
David Straus
27 papers
LF
Lorenzo Falchi
27 papers · 6 as a fellow

Clinical trials

A Study of Glofitamab and Lenalidomide in People With Mantle Cell Lymphoma
Principal investigator · Active not recruiting · Phase 1
Memorial Sloan Kettering Cancer Center
2024–2028
A Study of Tafasitamab and Lenalidomide in People With Mantle Cell Lymphoma
Principal investigator · Terminated · Phase 2
Memorial Sloan Kettering Cancer Center
2023–2024
The Study of Bendamustine, Rituximab, Ibrutinib, and Venetoclax in Relapsed, Refractory Mantle Cell Lymphoma
Principal investigator · Completed · Early phase 1
Memorial Sloan Kettering Cancer Center
2017–2024
Sequential Chemotherapy and Lenalidomide Followed by Rituximab and Lenalidomide Maintenance for Untreated Mantle Cell Lymphoma
Principal investigator · Completed · Phase 2
Memorial Sloan Kettering Cancer Center
2015–2023